[1]
Dhone Pravin, G., Rahul, G., Padmini, S. and Mubeen, M.F. 2022. To evaluate the efficacy and safety profile of Rosuvastatin, Simvastatin and Atorvastatin in newly diagnosed type 2 diabetic patients with dyslipidaemia. International journal of health sciences. 6, S4 (Jun. 2022), 5658–5666. DOI:https://doi.org/10.53730/ijhs.v6nS4.10009.